medicine-products/anti-tissue-transglutaminase-igg-assay-19105-1/;msg90356

Breaking Biology Technology:Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2 Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3 Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3 WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2

[0] Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project [0] Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer [0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia [0] WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening

Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2 FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3 Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2 Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3 CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2 CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3 5 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 1 5 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 2 5 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 3 5 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 4 5 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 5 Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 1 Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 2 Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 3 NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 1 NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 2 NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 3 NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 4

[0] FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging [0] Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million [0] CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition